Incidence and survival trends in adolescents and young adults with carcinoma of unknown primary: Insights from the SEER database (2000–2021).

O Omar Kamel (South valley university, Sohag, Egypt) F Faizan Ahmed A Aman Ullah U Umar Iqbal (Human Health Therapeutics Research Center National Research Council Canada Ottawa Canada) T Tehmasp Mirza (Shalamar Medical and Dental College, Lahore, Pakistan) A Abdullah Zia (6Ameer-ud-din Medical College, Lahore, Pakistan) N Najam Gohar (Ameer-ud-Din Medical College, Sialkot, Pakistan) S Sherif Eltawansy M Mohammad Hossain I Izzah Nayyab (Allama Iqbal Medical College, Lahore, Pakistan) M Mohamed Bakr (Jersey Shore, New Jersey, NJ) H Husnain Ahmad (Shalamar Medical and Dental College, Lahore, Pakistan) K Kainat Aman (Batterjaee Medical College, Jeddah, Saudi Arabia) M Maryam Nasir (6Ameer-ud-din Medical College, Lahore, Pakistan) A Ammara Fayyaz (Central Park Medical College, Lahore, punjab, Pakistan)

Abstract

e22586 Background: Carcinoma of Unknown Primary (CUP) among adolescents and young adults (AYA, ages 15–39) poses unique challenges due to diagnostic uncertainty and age-specific disparities in outcomes. This study leverages SEER data to evaluate incidence trends, survival outcomes, and mortality risks across AYA cohorts. Methods: SEER*Stat data (2000–2021) were analyzed for CUP incidence and survival in AYAs. Age-stratified cohorts (15–19, 20–24, 25–29, 30–34, and 35–39 years) were assessed for Annual Percent Changes (APC), Percent Changes (PC), and survival probabilities. Cox proportional hazards models quantified mortality risks across age and sex. Results: CUP incidence declined across all age groups, with significant reductions in the 20–24-year (APC: -3.0%, p < 0.05), 30–34-year (APC: -2.7%, p < 0.05), and 35–39-year (APC: -2.6%, p < 0.05) cohorts. Younger patients demonstrated superior survival outcomes, with a 60-month relative survival of 38.4% (15–19 years) compared to 29.7% (35–39 years). Median survival times also declined with age, from 28.0 months in the youngest cohort to 10.0 months in the oldest. Hazard ratios for mortality increased progressively with age, from 2.45 (15–19 years) to 3.59 (35–39 years), with statistically significant trends (p < 0.001). Wide confidence intervals in younger cohorts highlight data variability due to small sample sizes. Conclusions: This study highlights significant age-related disparities in CUP incidence and survival among AYAs. While incidence has declined, older AYAs continue to face poor survival outcomes, emphasizing the need for age-specific diagnostic and therapeutic strategies.

Article Details

Volume / Issue Vol. 43, Issue 16_suppl
Published June 01, 2025
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (15)

O

Omar Kamel

South valley university, Sohag, Egypt

F

Faizan Ahmed

A

Aman Ullah

U

Umar Iqbal

Human Health Therapeutics Research Center National Research Council Canada Ottawa Canada

T

Tehmasp Mirza

Shalamar Medical and Dental College, Lahore, Pakistan

A

Abdullah Zia

6Ameer-ud-din Medical College, Lahore, Pakistan

N

Najam Gohar

Ameer-ud-Din Medical College, Sialkot, Pakistan

S

Sherif Eltawansy

M

Mohammad Hossain

I

Izzah Nayyab

Allama Iqbal Medical College, Lahore, Pakistan

M

Mohamed Bakr

Jersey Shore, New Jersey, NJ

H

Husnain Ahmad

Shalamar Medical and Dental College, Lahore, Pakistan

K

Kainat Aman

Batterjaee Medical College, Jeddah, Saudi Arabia

M

Maryam Nasir

6Ameer-ud-din Medical College, Lahore, Pakistan

A

Ammara Fayyaz

Central Park Medical College, Lahore, punjab, Pakistan